• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗氧化剂在甲状腺眼病中作用的系统评价

A Systematic Review on the Role of Antioxidants in Thyroid Eye Disease.

作者信息

Akbarian Shadi, Chaibakhsh Samira, Kashkouli Mohsen Bahmani, Karimi Nasser, Abdolalizadeh Parya, Ghahvehchian Hossein

机构信息

Eye Research Center, The Five Senses Institute, Iran University of Medical Sciences, Tehran, Iran.

Skull Base Research Center, Eye Research Center, The Five Senses Institute, Iran University of Medical Sciences, Tehran, Iran.

出版信息

J Curr Ophthalmol. 2022 Apr 16;34(1):16-24. doi: 10.4103/joco.joco_266_21. eCollection 2022 Jan-Mar.

DOI:10.4103/joco.joco_266_21
PMID:35620378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9128423/
Abstract

PURPOSE

To systematically review the role of antioxidants in management of patients with thyroid eye disease (TED).

METHODS

A literature search of the electronic databases was performed without restrictions on the date of publication till the end of March 2021, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Clinical trials, case-control studies, cohorts, case series, case reports, and experimental (including ) studies in the English language were included. The primary outcome in human studies was improvement in severity, activity scores, and/or quality of life scores. There was a decrease in the level of HO-dependent oxidative stress, Hyaluronic acid release, reactive oxygen species, cell proliferation, or antifibrotic/antiproliferative actions in the studies.

RESULTS

Out of 374 initially screened articles, 157 studies were selected, the full texts of 82 were reviewed, and 14 papers were finally included. There were 4 clinical and 10 studies from 1993 to 2018. While β-carotene, retinol, Vitamin E, Vitamin C, melatonin, resveratrol, N-acetyl-l-cysteine, and quercetin showed some efficacy in studies; allopurinol, nicotinamide, pentoxifylline, and selenium (Se) were effective in both clinical and experimental reports. Se was the only recommended antioxidant based on one high-level randomized controlled trial.

CONCLUSION

While different antioxidants could potentially be effective in the management of TED, no strong recommendation for any or combination of antioxidants could be made to be implemented in the daily practice.

摘要

目的

系统评价抗氧化剂在甲状腺眼病(TED)患者管理中的作用。

方法

按照系统评价和Meta分析的首选报告项目指南,对电子数据库进行文献检索,检索截止至2021年3月底,不受发表日期限制。纳入英文的临床试验、病例对照研究、队列研究、病例系列研究、病例报告及实验性(包括……)研究。人体研究的主要结局为严重程度、活动评分和/或生活质量评分的改善。在……研究中,HO依赖性氧化应激水平、透明质酸释放、活性氧、细胞增殖或抗纤维化/抗增殖作用降低。

结果

在最初筛选的374篇文章中,选择了157项研究,对其中82篇的全文进行了综述,最终纳入14篇论文。有1993年至2018年的4项临床研究和10项……研究。虽然β-胡萝卜素、视黄醇、维生素E、维生素C、褪黑素、白藜芦醇、N-乙酰半胱氨酸和槲皮素在……研究中显示出一定疗效;别嘌醇、烟酰胺、己酮可可碱和硒(Se)在临床和实验报告中均有效。基于一项高水平随机对照试验,Se是唯一被推荐的抗氧化剂。

结论

虽然不同的抗氧化剂可能对TED的管理有效,但在日常实践中,无法对任何一种或多种抗氧化剂组合给出强有力的推荐建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/9128423/b44d1d6f1fb1/JCO-34-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/9128423/b44d1d6f1fb1/JCO-34-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/9128423/b44d1d6f1fb1/JCO-34-16-g001.jpg

相似文献

1
A Systematic Review on the Role of Antioxidants in Thyroid Eye Disease.抗氧化剂在甲状腺眼病中作用的系统评价
J Curr Ophthalmol. 2022 Apr 16;34(1):16-24. doi: 10.4103/joco.joco_266_21. eCollection 2022 Jan-Mar.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Antioxidants for female subfertility.用于女性生育力低下的抗氧化剂。
Cochrane Database Syst Rev. 2013 Aug 5(8):CD007807. doi: 10.1002/14651858.CD007807.pub2.
5
Antioxidants for female subfertility.用于女性生育力低下的抗氧化剂。
Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD007807. doi: 10.1002/14651858.CD007807.pub3.
6
Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO).β-胡萝卜素的抗氧化作用,而不是视黄醇和维生素 E,在格雷夫斯眼病(GO)患者的眼眶成纤维细胞中。
J Endocrinol Invest. 2018 Jul;41(7):815-820. doi: 10.1007/s40618-017-0809-5. Epub 2017 Dec 18.
7
Antioxidants for Skin Health.用于皮肤健康的抗氧化剂。
Recent Adv Food Nutr Agric. 2024 Aug 6. doi: 10.2174/012772574X311177240710100118.
8
Antioxidant supplementation for lung disease in cystic fibrosis.囊性纤维化肺病的抗氧化剂补充治疗
Cochrane Database Syst Rev. 2014 Aug 7(8):CD007020. doi: 10.1002/14651858.CD007020.pub3.
9
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
10
Antioxidant micronutrients for lung disease in cystic fibrosis.用于治疗囊性纤维化肺部疾病的抗氧化微量营养素
Cochrane Database Syst Rev. 2010 Dec 8(12):CD007020. doi: 10.1002/14651858.CD007020.pub2.

引用本文的文献

1
Mitigating the risks: addressing smoking cessation in thyroid eye disease.降低风险:解决甲状腺眼病中的戒烟问题。
BMJ Open Ophthalmol. 2025 Aug 31;10(1):e002226. doi: 10.1136/bmjophth-2025-002226.
2
Selenium vs Control for Graves Ophthalmopathy in a Selenium-Sufficient Area: A Randomized Clinical Trial.在硒充足地区,硒与对照组治疗格雷夫斯眼病的随机临床试验
JAMA Ophthalmol. 2025 Feb 27;143(4):287-94. doi: 10.1001/jamaophthalmol.2024.6337.
3
A Review of Pathophysiology and Therapeutic Strategies Targeting TGF-β in Graves' Ophthalmopathy.

本文引用的文献

1
Anti-inflammatory and Antioxidant Effects of Selenium on Orbital Fibroblasts of Patients With Graves Ophthalmopathy.硒对格雷夫斯眼病患者眼眶成纤维细胞的抗炎和抗氧化作用。
Ophthalmic Plast Reconstr Surg. 2021;37(5):476-481. doi: 10.1097/IOP.0000000000001931.
2
Antioxidant Therapy in Graves' Orbitopathy.Graves 眼病的抗氧化治疗。
Front Endocrinol (Lausanne). 2020 Dec 14;11:608733. doi: 10.3389/fendo.2020.608733. eCollection 2020.
3
The effect of thyroid hormone status on selected antioxidant parameters in patients with Graves' disease and active thyroid-associated orbitopathy.
《Graves 眼病中 TGF-β的病理生理学和治疗策略综述》
Cells. 2024 Sep 5;13(17):1493. doi: 10.3390/cells13171493.
4
Thyroid-associated ophthalmopathy: the role of oxidative stress.甲状腺相关眼病:氧化应激的作用。
Front Endocrinol (Lausanne). 2024 Jul 11;15:1400869. doi: 10.3389/fendo.2024.1400869. eCollection 2024.
5
The Role of Fibrogenesis and Extracellular Matrix Proteins in the Pathogenesis of Graves' Ophthalmopathy.纤维生成和细胞外基质蛋白在格雷夫斯眼病发病机制中的作用。
Int J Mol Sci. 2024 Mar 14;25(6):3288. doi: 10.3390/ijms25063288.
6
Is beta-carotene consumption associated with thyroid hormone levels?β-胡萝卜素的摄入与甲状腺激素水平有关吗?
Front Endocrinol (Lausanne). 2023 May 26;14:1089315. doi: 10.3389/fendo.2023.1089315. eCollection 2023.
甲状腺激素状态对格雷夫斯病和活动性甲状腺相关眼病患者某些抗氧化参数的影响。
Endokrynol Pol. 2020;71(5):418-424. doi: 10.5603/EP.a2020.0049. Epub 2020 Aug 14.
4
Approaches and Methods to Measure Oxidative Stress in Clinical Samples: Research Applications in the Cancer Field.临床样本中氧化应激的测量方法及手段:癌症领域的研究应用。
Oxid Med Cell Longev. 2019 Mar 12;2019:1279250. doi: 10.1155/2019/1279250. eCollection 2019.
5
Serum Trace Elements Profile in Graves' Disease Patients with or without Orbitopathy in Northeast China.中国东北地区 Graves 病伴或不伴眼病患者的血清微量元素谱。
Biomed Res Int. 2018 Jan 10;2018:3029379. doi: 10.1155/2018/3029379. eCollection 2018.
6
Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study.某特定中心自身免疫性甲状腺疾病患者的血清硒和硒蛋白-P水平:一项横断面研究。
Arch Endocrinol Metab. 2017 Dec;61(6):600-607. doi: 10.1590/2359-3997000000309.
7
Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO).β-胡萝卜素的抗氧化作用,而不是视黄醇和维生素 E,在格雷夫斯眼病(GO)患者的眼眶成纤维细胞中。
J Endocrinol Invest. 2018 Jul;41(7):815-820. doi: 10.1007/s40618-017-0809-5. Epub 2017 Dec 18.
8
Update on Graves disease: advances in treatment of mild, moderate and severe thyroid eye disease.格雷夫斯病最新进展:轻、中、重度甲状腺眼病的治疗进展
Curr Opin Ophthalmol. 2017 Sep;28(5):505-513. doi: 10.1097/ICU.0000000000000402.
9
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves' orbitopathy (GO): a new frontier for GO treatment?三种生物可利用抗氧化剂在格雷夫斯眼病(GO)患者眼眶成纤维细胞中的作用:GO 治疗的新前沿?
J Endocrinol Invest. 2018 Feb;41(2):193-201. doi: 10.1007/s40618-017-0718-7. Epub 2017 Jun 27.
10
Is selenium supplementation in autoimmune thyroid diseases justified?自身免疫性甲状腺疾病中补充硒是否合理?
Curr Opin Endocrinol Diabetes Obes. 2017 Oct;24(5):348-355. doi: 10.1097/MED.0000000000000356.